Arrowhead Research reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.28M 0M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Ligand Pharmaceuticals LGND:US $ 176.54M 144.18M
Merk MRK:US $ 30586M 104M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 646M 47M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 24373M 150M
Opko Health OPK:US $ 216.36M 23.28M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Tg Therapeutics TGTX:US $ 67.25M 0.46M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.41M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M